According to Pharma Mar's latest financial reports and stock price the company's current Operating Margin is 12.06%. At the end of 2021 the company had an Operating Margin of 41.39%.
Year | Operating Margin | Change |
---|---|---|
2021 | 41.39% | -23.26% |
2020 | 53.94% | -313.76% |
2019 | -25.23% | 118.76% |
2018 | -11.53% | -9.52% |
2017 | -12.75% | -6.62% |
2016 | -13.65% | -538.51% |
2015 | 3.11% | -68.03% |
2014 | 9.74% | -0.91% |
2013 | 9.82% | 44.07% |
2012 | 6.82% | 813.73% |
2011 | 0.75% | -107.87% |
2010 | -9.48% | -55.39% |
2009 | -21.25% | -47.97% |
2008 | -40.84% | -25.72% |
2007 | -54.99% | -13.82% |
2006 | -63.81% | -90.05% |
2005 | -641.40% | 110.34% |
2004 | -304.93% | 744.04% |
2003 | -36.13% | -45.44% |
2002 | -66.21% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.